Aspen Aerogels, Inc. (NYSE:ASPN – Get Free Report) has been assigned a consensus rating of “Hold” from the seven analysts that are covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and four have given a buy rating to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $5.9375.
Several research analysts have commented on the stock. Wall Street Zen cut shares of Aspen Aerogels from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. B. Riley Financial reiterated a “buy” rating on shares of Aspen Aerogels in a research note on Friday, August 7th. Barclays increased their target price on Aspen Aerogels from $4.00 to $5.00 and gave the company an “underweight” rating in a report on Tuesday, August 11th. Weiss Ratings restated a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Wednesday, June 24th. Finally, Roth Capital reaffirmed a “buy” rating and set a $7.75 price objective on shares of Aspen Aerogels in a research report on Friday, August 7th.
Get Our Latest Stock Analysis on ASPN
Hedge Funds Weigh In On Aspen Aerogels
Aspen Aerogels Trading Up 3.0%
NYSE ASPN opened at $4.90 on Friday. The firm has a 50 day simple moving average of $5.20 and a 200-day simple moving average of $4.74. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.24 and a current ratio of 2.52. Aspen Aerogels has a one year low of $2.30 and a one year high of $9.35. The firm has a market cap of $406.90 million, a price-to-earnings ratio of -3.20 and a beta of 2.97.
Aspen Aerogels (NYSE:ASPN – Get Free Report) last released its earnings results on Thursday, August 6th. The construction company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.23) by $0.01. The firm had revenue of $49.85 million during the quarter, compared to analysts’ expectations of $42.42 million. Aspen Aerogels had a negative return on equity of 31.12% and a negative net margin of 62.45%.Aspen Aerogels has set its Q3 2026 guidance at -0.110–0.070 EPS. Equities research analysts anticipate that Aspen Aerogels will post -0.69 EPS for the current fiscal year.
Aspen Aerogels Company Profile
Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.
The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.
Further Reading
- Five stocks we like better than Aspen Aerogels
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.
